Three Pillars to Growth: Advancing a Leading Allergy Immunotherapy Company

01

02

03

Expanding in Europe
Strong pipeline
Preparing for US entry
Strongly performing profitable businessNew technologies underpin pipeline breadth and depthSignificant opportunity in largest allergy market
Growing market share and additional product registrationsInvestment strategy supported by growing revenue streamChanging regulatory and reimbursement environment to drive market share towards Allergy's products